期刊文献+

影响肿瘤患者化疗疗效的医源性因素分析 被引量:7

Analysis of Medical Influencing Factors of Chemotherapy Effects in Tumor Patients
原文传递
导出
摘要 目的:提高肿瘤患者化疗的疗效。方法:从医师、药师、护士3个医疗环节中分析影响肿瘤患者化疗疗效的医源性因素。结果:影响肿瘤患者化疗疗效的医源性因素包括:药物相互作用;溶媒的选用、溶媒的用量;冲配时间、冲配计算、冲配方法、冲配容器;给药途径、给药顺序、给药速度等方面。结论:医疗环节中的不合理、不规范、不专业都会造成患者化疗疗效的降低或不良反应的发生。 OBJECTIVE:To improve the efficacy of cancer chemotherapy.METHODS:Medical influencing factors of chemotherapy effects were analyzed from physicians,pharmacists and nurses.RESULTS:Medical influencing factors of chemotherapy effects included drug interactions;choice and amount of solvent;calculation,methods,duration and containers of admixture;ways,sequence and speed of administration,etc.CONCLUSIONS:Irrational,non-standard,non-professional handlings in medical process will result in reduction of chemotherapy effects or the occurrence of adverse reactions.
出处 《中国药房》 CAS CSCD 2012年第14期1327-1329,共3页 China Pharmacy
关键词 化疗 合理用药 药物相互作用 医源性因素 Chemotherapy Rational drug use Drug interaction Medical influencing factors
  • 相关文献

参考文献6

二级参考文献19

共引文献103

同被引文献86

  • 1郭丽娟,张鸿雁,蔡珩玉.程序化输液预防化学性静脉炎[J].护士进修杂志,2005,20(1):81-82. 被引量:62
  • 2国家药典委员会.中国药典临床用药须知[S].北京:人民卫生出版社,2005:467.
  • 3邹栩,顾凯.世界新药研发动向[J].中国新药杂志,2007,16(22):1821-1825. 被引量:5
  • 4McKee M, Frei BL, Garcia A, et al. Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic [ J ]. J Oncol Pharm Pract,2011 , 17 (4) :387-394.
  • 5Feday J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 vl.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [ EB/OL ]. Lyon, France: International Agency for Research on Cancer, 2013. http://globocan.iare. fr/Pages/faet_sheets_caneer.aspx.
  • 6Gkiozos I, Charpidou A, Syrigos K. Developments in the treatment of non-small cell lung cancer [J]. Anticancer Res, 2007, 27(4C): 2823-2827.
  • 7Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual [M]. 7 th Ed. Newyork: Springer, 2010: 253-270.
  • 8NCCN. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer Vision 1 [ EB/OL ]. 2014. http://www.nccn.org/patients/.
  • 9Pallis AG, Gridelli C, Wedding U, et al. Management of elderly patients with NSCLC; updated expert' s opinion paper:EORTC Elderly Task Force, Lung Cancer Group and Inter- national Society for Geriatric Oncology [J] Ann Oncol, 2014, 25(7): 1270-1283.
  • 10Reck M, Popat S, Reinmuth N, et al. Metastatic non-small- cell lung cancer (NSCLC): ESMO Clinical Practice Guide- lines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2014, 25 Suppl 3: iii27-39,.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部